Clarification of the ongoing CE marking process.
Due to widespread speculation about the ongoing CE marking process of Actiste , the Company hereby wishes to clarify that all technical documentation has indeed been submitted to the designated Notified Body. For further information, please contact: Truls Sjöstedt, CEO Phone: +46 709 73 46 00 Email: truls.sjostedt@brighter.se Henrik Norström, COO Phone: +46 733 40 30 45 Email: henrik.norstrom@brighter.se About ActisteBrighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single